↓ Skip to main content

American Association for Cancer Research

Article Metrics

Optimization of antibody binding to FcγRIIa enhances macrophage phagocytosis of tumor cells

Overview of attention for article published in Molecular Cancer Therapeutics, August 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

patent
79 patents

Citations

dimensions_citation
210 Dimensions

Readers on

mendeley
220 Mendeley
Title
Optimization of antibody binding to FcγRIIa enhances macrophage phagocytosis of tumor cells
Published in
Molecular Cancer Therapeutics, August 2008
DOI 10.1158/1535-7163.mct-08-0201
Pubmed ID
Authors

John O. Richards, Sher Karki, Greg A. Lazar, Hsing Chen, Wei Dang, John R. Desjarlais

Mendeley readers

The data shown below were compiled from readership statistics for 220 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 1%
Germany 1 <1%
Belgium 1 <1%
Australia 1 <1%
Unknown 214 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 83 38%
Student > Ph. D. Student 39 18%
Student > Master 20 9%
Other 16 7%
Student > Doctoral Student 10 5%
Other 22 10%
Unknown 30 14%
Readers by discipline Count As %
Agricultural and Biological Sciences 84 38%
Biochemistry, Genetics and Molecular Biology 32 15%
Immunology and Microbiology 25 11%
Medicine and Dentistry 16 7%
Engineering 7 3%
Other 25 11%
Unknown 31 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 June 2021.
All research outputs
#1,938,706
of 18,439,562 outputs
Outputs from Molecular Cancer Therapeutics
#245
of 3,326 outputs
Outputs of similar age
#48,612
of 289,990 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#7
of 50 outputs
Altmetric has tracked 18,439,562 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,326 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 289,990 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.